Seqens CEO Pierre Luzeau and Christophe Eychenne-Baron, director of global research and development, speak with state Sen.Jamie Eldridge and state Rep. Dan Sena during a tour after a ribbon-cutting ceremony for Seqens’ new lab in Devens, Jan. 31. (Photo by Lisa Aciukewicz)
Parlez-vous ‘pharma’
